Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation.

By M. Sabatine, C. Cannon, C. Gibson, J. López-Sendón, G. Montalescot, P. Théroux, M. Claeys, F. Cools, K. A. Hill, A. Skene and 2 more. New England Journal of Medicine, 2005

1,727 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Immunology

View Paper: https://www.semanticscholar.org/paper/9570ef5387090df37124cd80c0b54e4db5ef01d3

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

1. P. O'Gara
2. Jeroen J. Bax
3. Gerasimos Filippatos
4. M. Mack
5. L. Fleisher
6. E. Braunwald

Citations in the corpus

• ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. (2012, positive): “Infarction Trial (COMMIT), clopidogrel reduced overall mortality in such patients.(156,157) Accordingly, there is a good case for the”
• Effect of clopidogrel pretreatment before percutaneous coronary intervention in patients with ST-elevation myocardial infarction treated with fibrinolytics: the PCI-CLARITY study. (2005, methodology): “In the Clopidogrel as Adjunctive Reperfusion Therapy (CLARITY)– Thrombolysis in Myocardial Infarction (TIMI) 28 trial, patients with STsegment elevation myocardial infarction (STEMI) receiving a fibrinolytic were randomized on presentation to receive clopidogrel (including a loading dose) or placebo”
• Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology. (2008, result): “The rates of major bleeding and intracranial haemorrhage were similar in the two groups.(52) In the COMMIT study,(80) 45 852 Chinese patients of any age (but ,1000 patients .”